|
IN186315B
(es)
*
|
1996-12-12 |
2001-08-04 |
Panacea Biotec Ltd |
|
|
GT199800127A
(es)
*
|
1997-08-29 |
2000-02-01 |
|
Combinaciones terapeuticas.
|
|
EA002705B1
(ru)
*
|
1997-08-29 |
2002-08-29 |
Пфайзер Продактс Инк. |
Комбинационная терапия, включающая в себя амлодипин и статиновое соединение
|
|
US20040029962A1
(en)
*
|
1997-12-12 |
2004-02-12 |
Chih-Ming Chen |
HMG-COA reductase inhibitor extended release formulation
|
|
US5916595A
(en)
*
|
1997-12-12 |
1999-06-29 |
Andrx Pharmaceutials, Inc. |
HMG co-reductase inhibitor
|
|
US8679534B2
(en)
*
|
1997-12-12 |
2014-03-25 |
Andrx Labs, Llc |
HMG-CoA reductase inhibitor extended release formulation
|
|
EP0935964A1
(en)
*
|
1998-02-12 |
1999-08-18 |
Panacea Biotec Limited |
Pharmaceutical compositions containing NSAIDs and piperine
|
|
GB9812426D0
(en)
*
|
1998-06-10 |
1998-08-05 |
Reckitt & Colmann Prod Ltd |
Improvements in or relating to organic compositions
|
|
US6524620B2
(en)
|
1998-07-20 |
2003-02-25 |
Andrx Pharmaceuticals, Inc. |
Diltiazem controlled release formulation and method of manufacture
|
|
US6054585A
(en)
*
|
1998-12-23 |
2000-04-25 |
Sabinsa Corporation |
Process for making high purity piperine for nutritional use
|
|
US6316020B1
(en)
|
1999-08-26 |
2001-11-13 |
Robert R. Whittle |
Pharmaceutical formulations
|
|
US6262085B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
|
US6780880B1
(en)
|
1999-08-26 |
2004-08-24 |
Robert R. Whittle |
FT-Raman spectroscopic measurement
|
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
|
US6268385B1
(en)
|
1999-08-26 |
2001-07-31 |
Robert R. Whittle |
Dry blend pharmaceutical formulations
|
|
US6326384B1
(en)
|
1999-08-26 |
2001-12-04 |
Robert R. Whittle |
Dry blend pharmaceutical unit dosage form
|
|
US6312723B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
|
US6312712B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Method of improving bioavailability
|
|
US6262086B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
|
NZ518770A
(en)
*
|
1999-11-08 |
2004-02-27 |
Andrx Corp |
HMG-COA reductase inhibitor extended release formulation
|
|
IL141438A0
(en)
*
|
2000-02-23 |
2002-03-10 |
Pfizer Prod Inc |
Method of increasing the bioavailability and tissue penetration of azithromycin
|
|
DE10196213T1
(de)
*
|
2000-05-19 |
2003-04-30 |
Sabinsa Corp |
Verfahren erhöhter Bioverfügbarkeit von Nährstoffen und pharmazeutische Präparationen mit Tetrahydropiperin und Analoga und Derivaten davon
|
|
EA005672B1
(ru)
*
|
2000-06-28 |
2005-04-28 |
Бакулиш Мафатлал Хамар |
Хемосенсибилизатор
|
|
MXPA03003401A
(es)
*
|
2000-10-16 |
2004-06-30 |
Neopharm Inc |
Formulacion liposomica de mitoxantrona.
|
|
IT1320180B1
(it)
*
|
2000-12-29 |
2003-11-26 |
Hunza Di Marazzita Maria Carme |
Preparazioni nutrizionali e terapeutiche dotate di attivita'antiossidante ed in grado di controllare gli eccessi ponderali e
|
|
US20030068276A1
(en)
*
|
2001-09-17 |
2003-04-10 |
Lyn Hughes |
Dosage forms
|
|
ATE344665T1
(de)
*
|
2002-04-04 |
2006-11-15 |
Cadila Pharmaceuticals Ltd |
Verfahren zur herstellung einer einen antiretroviralen proteasehemmer enthaltenden pharmazeutischen zusammensetzung mit verbesserter bioverfügbarkeit
|
|
US20070249537A1
(en)
*
|
2003-01-23 |
2007-10-25 |
Supernus Pharmaceuticals, Inc. |
Absorption enhancing agents
|
|
JP4589126B2
(ja)
*
|
2003-03-31 |
2010-12-01 |
カウンシル オブ サイエンティフィク アンド インダストリアル リサーチ |
抗感染剤の生物学的有効性に影響を及ぼすためのクミン（ｃｕｍｉｎｕｍｃｙｍｉｎｕｍ）抽出物及びピペリンの使用
|
|
US20070087055A1
(en)
*
|
2005-10-14 |
2007-04-19 |
David Jan |
Directly compressible extended release alprazolam formulation
|
|
EP2011495A1
(en)
*
|
2007-07-03 |
2009-01-07 |
Sygnis Bioscience GmbH & Co. KG |
Use of piperine and derivatives thereof for the therapy of neurological conditions
|
|
US20090297622A1
(en)
*
|
2008-01-01 |
2009-12-03 |
Khorshid Faten A |
Separation and formulation of bioactive fraction and subfraction from camel urine work as anticancer agent
|
|
ES2547466T3
(es)
|
2009-06-17 |
2015-10-06 |
Fatin A. Khorshid |
Separación y formulación de fracción bioactiva y trabajo de subfracción de orina de camello como agente anticáncer
|
|
US20140348926A1
(en)
|
2012-01-19 |
2014-11-27 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Formulation and method for increasing oral bioavailability of drugs
|
|
CN111246847A
(zh)
*
|
2017-08-25 |
2020-06-05 |
聪明智商股份有限公司 |
包含植物营养素和适应原草药的功能性咀嚼胶
|
|
WO2019058386A1
(en)
|
2017-09-19 |
2019-03-28 |
Cipla Limited |
COMPOSITIONS COMPRISING IBRUTINIB AND AN ALKALOID HAVING IMPROVED BIOAVAILABILITY
|